ROBINS HARLAN S (Chief Scientific Officer) sold 27.5% of their position (386.24K shares) of ADAPTIVE BIOTECHNOLOGIES CORP on the open market
Open‑market sale worth $8.50M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 7/7/2026ACC: 0001780851-26-000015
Officer· Chief Scientific Officer
Since Jun 2019
-386.24K
Net shares
Net seller
$8.50M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
386.24K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−239.35K
Price / share
$21.74
Trade value
$5.20M
% of position
17.0%
7/2/2026
1.41M→1.17M
Common Stock
Direct
Shares
−146.89K
Price / share
$22.45
Trade value
$3.30M
% of position
12.6%
7/2/2026
1.17M→1.02M
Total
Net shares
−386.24K
Net value
-$8.50M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/2/2026 | S · Sale | −239.35K | $21.74 | $5.20M | 17.0% | 1.41M | 1.17M |
| Common Stock Direct | 7/2/2026 | S · Sale | −146.89K | $22.45 | $3.30M | 12.6% | 1.17M | 1.02M |
| Total | −386.24K | -$8.50M | ||||||
Derivative Transactions0
No derivative transactions reported